Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Cytovance Biologics, Inc. announces that it has teamed up with NeuroFx to develop and manufacture stem cell derived, cell-free therapy for neurological conditions.
read more
Cytovance Biologics, Inc., a leading full-service contract manufacturer ("CMO") of mammalian and microbial biologics, is pleased to participate in the Buzz of BIO for the 2014 BIO International Convention. Hosted by the Biotechnology Industry ...
read more
Wednesday, January 14, 2015
Cytovance® Biologics, Inc., a leading biopharmaceutical contract manufacturing company, announced the promotion of Donald Wuchterl to Chief Operating Officer. In this new capacity, Mr. Wuchterl will oversee Cytovance's Research & Development Services...
read more
Wednesday, January 14, 2015
Cytovance Biologics, Inc. is pleased to announce the appointment of Seth Fisher as Director of Purification Development in the R&D Services group.
read more
Cytovance Biologics, Inc., a leading full-service contract manufacturer (“CMO”) of mammalian and microbial biologics, announces a development and manufacturing agreement with Selexys Pharmaceuticals, Corp., an Oklahoma City-based clinical stage ...
read more
Thursday, February 27, 2014
Cytovance Biologics, Inc., a leading full-service contract manufacturer (“CMO”) of mammalian and microbial biologics, announces that they have entered into a development and manufacturing agreement with Pamlico Biopharma, Inc., an Oklahoma City-based...
read more
Thursday, October 03, 2013
Cytovance Biologics, a leading full-service contract manufacturer (“CMO”) of mammalian and microbial biologics, announces that they have entered into a manufacturing agreement with Translational Sciences, Inc., a Memphis, Tennessee-based clinical ...
read more
Cytovance Biologics, Inc., a leading full-service contract manufacturer of mammalian and microbial biologics, has recently been named as one of Oklahoma City’s fastest growing private companies.
read more
Cytovance Biologics, a leading full-service contract manufacturing organization (“CMO”) of mammalian and microbial biologics, welcomes Mark Ambrose, Ph.D., as Senior Director of Quality Systems and Compliance and Anne Garstka as Director of ...
read more
Wednesday, August 22, 2018
Cytovance Biologics names Yan Wang, Ph.D., as Chief Executive Officer.
read more
Cytovance Biologics has announced the addition of an integrated single-use platform for the manufacturing of plasmid DNA (pDNA) at their facilities in Oklahoma City, OK.
read more
Cytovance® Biologics, Inc., a biopharmaceutical contract manufacturing organization specializing in the production of therapeutic proteins and antibodies from mammalian cell culture and microbial fermentation, has announced the addition of Francis (...
read more
Cytovance® Biologics announced it has received a notification letter and an EIRs from the FDA for its Oklahoma City site, FEI registration numbers: 3006341547.
read more
Thursday, February 06, 2014
Cytovance Biologics, Inc., a leading full-service contract manufacturer of mammalian and microbial biologics, broke ground on an expansion facility to contain both manufacturing operations and GMP warehousing. The multi-million dollar capital ...
read more
Cytovance® Biologics has announced the appointment of Dr. Jesse McCool to Chief Executive Officer.
read more